
TY  - JOUR
AU  - Kimber, Ian
AU  - Dearman, RJ
AU  - Ryan, CA
AU  - Gerberick, GF
TI  - Gene expression profiling in allergic contact dermatitis
JO  - Contact Dermatitis
VL  - 50
IS  - 3
SN  - 0105-1873
UR  - https://doi.org/10.1111/j.0105-1873.2004.0309ds.x
DO  - doi:10.1111/j.0105-1873.2004.0309ds.x
SP  - 171
EP  - 171
PY  - 2004
AB  - The successful acquisition of skin sensitisation requires orchestrated cellular and molecular interactions that collectively result in the induction of a cutaneous immune response of the required quality and vigour. Pivotal roles are played by epidermal Langerhans cells (LC), and by the mature immunostimulatory dendritic cells (DC) into which they mature. LC serve as sentinels of the adaptive immune system with responsibility for surveying changes in the local microenvironment and for processing antigen (and chemical allergens) encountered at skin surfaces. Following such encounters LC are mobilised and stimulated to migrate, via afferent lymphatics, to regional lymph nodes. While in transit they lose the properties of antigen processing cells and acquire instead the characteristics of mature DC that are able to interact effectively with, and present antigen to, T lymphocytes. To gain a greater understanding of the molecular events that induce and regulate cutaneous immune responses to chemical allergens, we have used microarray transcript profiling and related experimental approaches to characterise changes in gene expression and protein production associated with the development of skin sensitisation. Our attention has focused particularly on changes in the expression of mRNA and protein resulting from the interaction of chemical allergens with DC, and associated with the presentation of antigen to T lymphocytes.
ER  - 

TY  - JOUR
TI  - Free Communications
JO  - British Journal of Haematology
VL  - 129
IS  - s1
SN  - 0007-1048
UR  - https://doi.org/10.1111/j.1365-2141.2005.05435.x
DO  - doi:10.1111/j.1365-2141.2005.05435.x
SP  - 1
EP  - 83
PY  - 2005
ER  - 

TY  - JOUR
TI  - Primary Care SIG
JO  - Respirology
VL  - 14
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_13.x
DO  - doi:10.1111/j.1440-1843.2009.01503_13.x
SP  - A79
EP  - A80
PY  - 2009
ER  - 

TY  - JOUR
TI  - COPD SIG 2
JO  - Respirology
VL  - 14
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_6.x
DO  - doi:10.1111/j.1440-1843.2009.01503_6.x
SP  - A54
EP  - A57
PY  - 2009
ER  - 

TY  - JOUR
TI  - Thrombosis and haemostasis
JO  - European Journal of Clinical Investigation
VL  - 35
IS  - s2
SN  - 0014-2972
UR  - https://doi.org/10.1111/j.1365-2362.2005.1478_10.x
DO  - doi:10.1111/j.1365-2362.2005.1478_10.x
SP  - A108
EP  - A114
PY  - 2005
ER  - 

TY  - JOUR
TI  - Gastroenterology and hepatology
JO  - European Journal of Clinical Investigation
VL  - 35
IS  - s2
SN  - 0014-2972
UR  - https://doi.org/10.1111/j.1365-2362.2005.1478_3.x
DO  - doi:10.1111/j.1365-2362.2005.1478_3.x
SP  - A60
EP  - A69
PY  - 2005
ER  - 

TY  - JOUR
TI  - Invited Presentations
JO  - Nephrology
VL  - 3
IS  - S1
SN  - 1320-5358
UR  - https://doi.org/10.1111/j.1440-1797.1997.tb00554.x
DO  - doi:10.1111/j.1440-1797.1997.tb00554.x
SP  - S1
EP  - S630
PY  - 1997
ER  - 

TY  - JOUR
AU  - NAUGHTON, GAIL K.
TI  - From Lab Bench to Market
JO  - Annals of the New York Academy of Sciences
VL  - 961
IS  - 1
SN  - 0077-8923
UR  - https://doi.org/10.1111/j.1749-6632.2002.tb03127.x
DO  - doi:10.1111/j.1749-6632.2002.tb03127.x
SP  - 372
EP  - 385
KW  - scaffolds
KW  - bioreactors
KW  - cryopreservation
PY  - 2002
AB  - Abstract: Revolutionary advances in tissue engineering are redefining approaches to tissue repair and transplantation through the creation of replacement tissues that remain biointeractive after implantation, imparting physiologic functions as well as structure to the tissue or organ damaged by disease or trauma.1,2 Over the last decade this field has moved from ?science fiction? to ?science fact? with the research-oriented acceptance of its potential to regulatory approvals allowing commercial products to be available for use in many countries. The maintenance of tissue integrity, functionality, and viability from cell seeding through product manufacture, shipping, and end-use has been accomplished through innovations in design and scale-up of both tissue growth and preservation processes. These unique systems have enabled the delivery of tissue-engineered products that are uniform inter- and intra-lot, readily available as off-the-shelf products, easy to use, and efficacious. Skin replacement products are the most advanced, with several tissue-engineered wound care materials on the market in the U.S. and in several international communities.3-5 The potential impact of this field is far broader, offering novel solutions to the medical field for drug screening and development, genetic engineering, and total tissue and organ replacement.
ER  - 

TY  - JOUR
TI  - Abstract Presentations from the AABB Annual Meeting Philadelphia, PA, October 25-28, 2014
JO  - Transfusion
JA  - Transfusion
VL  - 54
IS  - S2
SN  - 0041-1132
UR  - https://doi.org/10.1111/trf.12845
DO  - doi:10.1111/trf.12845
SP  - 15A
EP  - 268A
PY  - 2014
ER  - 

TY  - JOUR
TI  - Paediatric SIG
JO  - Respirology
VL  - 14
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_12.x
DO  - doi:10.1111/j.1440-1843.2009.01503_12.x
SP  - A75
EP  - A79
PY  - 2009
ER  - 

TY  - JOUR
TI  - Respiratory Infectious Disease SIG
JO  - Respirology
VL  - 14
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_14.x
DO  - doi:10.1111/j.1440-1843.2009.01503_14.x
SP  - A80
EP  - A83
PY  - 2009
ER  - 

TY  - JOUR
TI  - Immunology, rheumatology
JO  - European Journal of Clinical Investigation
VL  - 35
IS  - s2
SN  - 0014-2972
UR  - https://doi.org/10.1111/j.1365-2362.2005.1478_5.x
DO  - doi:10.1111/j.1365-2362.2005.1478_5.x
SP  - A79
EP  - A87
PY  - 2005
ER  - 

TY  - JOUR
TI  - OLIV SIG 1 â€“ ILD/PAH/Other
JO  - Respirology
VL  - 14
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_10.x
DO  - doi:10.1111/j.1440-1843.2009.01503_10.x
SP  - A67
EP  - A70
PY  - 2009
ER  - 

TY  - JOUR
TI  - Cell Biology/Immunology SIG
JO  - Respirology
VL  - 14
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_4.x
DO  - doi:10.1111/j.1440-1843.2009.01503_4.x
SP  - A46
EP  - A51
PY  - 2009
ER  - 

TY  - JOUR
TI  - P05. Posters 5
JO  - Australasian Journal of Dermatology
VL  - 38
IS  - S2
SN  - 0004-8380
UR  - https://doi.org/10.1111/ajd.1997.38.s2.261
DO  - doi:10.1111/ajd.1997.38.s2.261
SP  - 261
EP  - 291
PY  - 1997
ER  - 

TY  - JOUR
TI  - Scientific
JO  - Transfusion
VL  - 47
IS  - s3
SN  - 0041-1132
UR  - https://doi.org/10.1111/j.1537-2995.2007.01507_1.x
DO  - doi:10.1111/j.1537-2995.2007.01507_1.x
SP  - 1A
EP  - 216A
PY  - 2007
ER  - 

TY  - JOUR
TI  - AASLD Abstracts
JO  - Hepatology
JA  - Hepatology
VL  - 58
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.26727
DO  - doi:10.1002/hep.26727
SP  - 208A
EP  - 1309A
PY  - 2013
ER  - 

TY  - JOUR
TI  - Administrative Operations
JO  - Transfusion
VL  - 47
IS  - s3
SN  - 0041-1132
UR  - https://doi.org/10.1111/j.1537-2995.2007.01507_2.x
DO  - doi:10.1111/j.1537-2995.2007.01507_2.x
SP  - 217A
EP  - 279A
PY  - 2007
ER  - 

TY  - JOUR
TI  - Administrative Operations
JO  - Transfusion
VL  - 46
IS  - 9s
SN  - 0041-1132
UR  - https://doi.org/10.1111/j.1537-2995.2006.01023_2.x
DO  - doi:10.1111/j.1537-2995.2006.01023_2.x
SP  - 165A
EP  - 233A
PY  - 2006
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Journal of Sleep Research
VL  - 21
IS  - s1
SN  - 0962-1105
UR  - https://doi.org/10.1111/j.1365-2869.2012.01044.x
DO  - doi:10.1111/j.1365-2869.2012.01044.x
SP  - 1
EP  - 371
PY  - 2012
ER  - 
